{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-25-001736","form_type":"8-K","ticker":"RFL","cik":"0001713863","company_name":"Rafael Holdings, Inc.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.561012+00:00","generated_at":"2026-05-24T05:52:58.513389+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Rafael Holdings stockholders approve share issuance for Cyclo Therapeutics merger","bullets":["Share issuance proposal passed with 3,706,261 votes For (99.92%) vs. 1,571 Against.","Adjournment proposal also approved with 3,676,323 For (99.77%) and 32,783 Against.","Special meeting held March 20, 2025; both proposals were stockholder votes required to proceed with merger.","Transaction involves exchange of Rafael Class B common stock for Cyclo common stock under August 2024 merger agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-25-001736","json":"https://secwatch.observer/filing/0001013762-25-001736.json","markdown":"https://secwatch.observer/filing/0001013762-25-001736.md","text":"https://secwatch.observer/filing/0001013762-25-001736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713863/000101376225001736/0001013762-25-001736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713863/000101376225001736/ea0235330-8k_rafael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:52:58.513389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}